Peltzer Karl, Weiss Stephen M, Soni Manasi, Lee Tae Kyoung, Rodriguez Violeta J, Cook Ryan, Alcaide Maria Luisa, Setswe Geoffrey, Jones Deborah L
HIV/AIDS/STIs and TB (HAST) Research Programme, Human Sciences Research Council, Pretoria, South Africa.
Department of Research & Innovation, University of Limpopo, Sovenga, South Africa.
AIDS Res Ther. 2017 Dec 16;14(1):61. doi: 10.1186/s12981-017-0187-2.
We evaluate the impact of clinic-based PMTCT community support by trained lay health workers in addition to standard clinical care on PMTCT infant outcomes.
In a cluster randomized controlled trial, twelve community health centers (CHCs) in Mpumalanga Province, South Africa, were randomized to have pregnant women living with HIV receive either: a standard care (SC) condition plus time-equivalent attention-control on disease prevention (SC; 6 CHCs; n = 357), or an enhanced intervention (EI) condition of SC PMTCT plus the "Protect Your Family" intervention (EI; 6 CHCs; n = 342). HIV-infected pregnant women in the SC attended four antenatal and two postnatal video sessions and those in the EI, four antenatal and two postnatal PMTCT plus "Protect Your Family" sessions led by trained lay health workers. Maternal PMTCT and HIV knowledge were assessed. Infant HIV status at 6 weeks postnatal was drawn from clinic PCR records; at 12 months, HIV status was assessed by study administered DNA PCR. Maternal adherence was assessed by dried blood spot at 32 weeks, and infant adherence was assessed by maternal report at 6 weeks. The impact of the EI was ascertained on primary outcomes (infant HIV status at 6 weeks and 12 months and ART adherence for mothers and infants), and secondary outcomes (HIV and PMTCT knowledge and HIV transmission related behaviours). A series of logistic regression and latent growth curve models were developed to test the impact of the intervention on study outcomes.
In all, 699 women living with HIV were recruited during pregnancy (8-24 weeks), and assessments were completed at baseline, at 32 weeks pregnant (61.7%), and at 6 weeks (47.6%), 6 months (50.6%) and 12 months (59.5%) postnatally. Infants were tested for HIV at 6 weeks and 12 months, 73.5% living infants were tested at 6 weeks and 56.7% at 12 months. There were no significant differences between SC and EI on infant HIV status at 6 weeks and at 12 months, and no differences in maternal adherence at 32 weeks, reported infant adherence at 6 weeks, or PMTCT and HIV knowledge by study condition over time.
The enhanced intervention administered by trained lay health workers did not have any salutary impact on HIV infant status, ART adherence, HIV and PMTCT knowledge. Trial registration clinicaltrials.gov: number NCT02085356.
我们评估了除标准临床护理外,由经过培训的非专业保健工作者提供的基于诊所的预防母婴传播社区支持对预防母婴传播婴儿结局的影响。
在一项整群随机对照试验中,南非姆普马兰加省的12个社区卫生中心(CHC)被随机分组,以使感染艾滋病毒的孕妇接受以下两种方式之一:标准护理(SC)组,即标准护理加在疾病预防方面与标准护理时间相当的注意力控制组(SC;6个社区卫生中心;n = 357),或强化干预(EI)组,即标准护理预防母婴传播加“保护你的家人”干预措施组(EI;6个社区卫生中心;n = 342)。SC组中感染艾滋病毒的孕妇参加了4次产前和2次产后视频课程,EI组的孕妇参加了4次产前和2次产后由经过培训的非专业保健工作者主持的预防母婴传播课程以及“保护你的家人”课程。评估了孕产妇预防母婴传播和艾滋病毒知识。产后6周时婴儿的艾滋病毒状况来自诊所的聚合酶链反应(PCR)记录;在12个月时,通过研究管理的DNA PCR评估艾滋病毒状况。在孕32周时通过干血斑评估孕产妇依从性,在产后6周时通过母亲报告评估婴儿依从性。确定了EI对主要结局(产后6周和12个月时婴儿的艾滋病毒状况以及母亲和婴儿的抗逆转录病毒治疗依从性)和次要结局(艾滋病毒和预防母婴传播知识以及与艾滋病毒传播相关的行为)的影响。开发了一系列逻辑回归和潜在增长曲线模型来测试干预对研究结局的影响。
总共在孕期(8 - 24周)招募了699名感染艾滋病毒的妇女,并在基线、孕32周(61.7%)、产后6周(47.6%)、6个月(50.6%)和12个月(59.5%)时完成了评估。在产后6周和12个月时对婴儿进行了艾滋病毒检测,73.5%存活的婴儿在6周时接受了检测,56.7%在12个月时接受了检测。在产后6周和12个月时,SC组和EI组在婴儿艾滋病毒状况方面没有显著差异,在孕32周时的孕产妇依从性、产后6周报告的婴儿依从性或不同研究条件下随时间推移的预防母婴传播和艾滋病毒知识方面也没有差异。
由经过培训的非专业保健工作者实施的强化干预对艾滋病毒婴儿状况、抗逆转录病毒治疗依从性、艾滋病毒和预防母婴传播知识没有任何有益影响。试验注册 clinicaltrials.gov:编号NCT02085356。